TTrialPathMatch Me to Trials
← Back to trials
RecruitingHeart Failure

Alleviant ALLAY-HFrEF Study

Eligible age

18+ yrs

Accepts

All genders

Locations

19 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.

Sponsor: Alleviant Medical, Inc.

You may qualify if…

  • ✓ LVEF ≤ 40%
  • ✓ NYHA class II, III or ambulatory IV HF
  • ✓ Receiving optimal, maximally tolerated, stable GDMT

You may not qualify if…

  • ✕ Advanced heart failure
  • ✕ Life-expectancy \< 12 months
  • ✕ Evidence of right heart dysfunction

Where it's recruiting

California

Los Angeles · Sacramento · San Diego · San Francisco

Florida

Delray Beach · Pensacola · Tampa

Georgia

Decatur

Illinois

Naperville

Louisiana

Houma · New Orleans

Minnesota

Minneapolis

Missouri

St Louis

Nevada

Las Vegas

New Jersey

Browns Mills · Englewood

New York

New York · Rochester

North Carolina

Asheville · Durham · Raleigh

Source: ClinicalTrials.gov · NCT06812533 · last updated 2026-10-06